FRIDAY, June 21, 2024 -- An experimental cancer treatment regimen is achieving full remissions in some patients with aggressive B-cell lymphoma,...

June 20, 2024 -- Researchers at the National Institutes of Health (NIH) have developed a non-chemotherapy treatment regimen that is achieving full...

Treatment outcomes for breast cancer have become better over the years, but proportion of breast cancers still recur even after long periods without...

Following the label expansion, AbbVie's (ABBV) Epkinly is the first bispecific antibody approved to treat relapsed/refractory (R/R) follicular...

Researchers found that the protein TIMP-1 plays a crucial role in the immune system's defense system.

Society of Nuclear Medicine and Molecular Imaging Annual Meeting Cleveland Clinic researchers have discovered a new location for a protein that helps...

THURSDAY, June 20, 2024 -- For patients with specific subtypes of relapsed or refractory diffuse large B-cell lymphoma (DLBCL), treatment with...

Researchers at the University of Turku in Finland discovered that TIMP-1, a protein traditionally known for protecting cells and tissues, also plays...

In a recent study, researchers have discovered a potential new biological target related to amyloid (and) #946; precursor-like protein 1 (Aplp1), a...

TUESDAY, June 25, 2024 -- Losing weight can protect you against cancers related to obesity, a new study finds. Obesity has been linked to higher risk...